Effects of Nattokinase on Cardiovascular Risk, Gut Microbiota, Sleep, and Cognition in Metabolic Syndrome With Sleep Disorders.
Clinical trial NCT07229521 · RECRUITING
Trial details
- NCT number
- NCT07229521
- Sponsor
- Taipei Medical University
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-15
- Primary completion
- 2026-12-11
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.